← Leaderboards
Brendan Patrick Cormack
University Of Maryland Baltimore
$9,770,001
Attributed
$9,770,001
Total exposure
11
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $941.2K · FY2005–23$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$9,770,001 · 11
By mechanism
R01$7,824,893 · 4
R21$1,490,764 · 4
P01$259,630 · 1
R56$186,714 · 1
R13$8,000 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Virulence”
- Ronald B Corley · Boston University Medical Campus$43,000,000
- Joseph Heitman · Duke University$29,765,716
- Vanessa Sperandio · University Of Wisconsin-Madison$29,177,087
- Adolfo Garcia-Sastre · Jackson Laboratory$28,883,338
- John J Mekalanos · Harvard Medical School$28,747,360
- Scott J Hultgren · Washington University$28,322,020
Research focus
VirulenceCandidiasisCandidaGenesGrowthGeneticGene ExpressionBaseInfectionRegulationSignal TransductionProteinsCellsCandida GlabrataCandida AlbicansDisseminated CandidiasisPathogenYeastsMediatingAccountingResponseGrantFamilyGenome
Grant awards (39)
Centrosome biogenesis and copy number control$339,500
R01 · FY2023 · GM · contact PI
Centrosome biogenesis and copy number control$48,572
R01 · FY2023 · GM · contact PI
Molecular mechanism that suppresses the proliferation of cells with supernumerary centrioles$422,076
R01 · FY2022 · GM · contact PI
Centrosome biogenesis and copy number control$340,138
R01 · FY2022 · GM · contact PI
Centrosome biogenesis and copy number control$72,856
R01 · FY2022 · GM · contact PI
Cryptococcal Exploitation of the Blood-Brain Barrier$204,688
R21 · FY2021 · AI · contact PI
Cryptococcus neoformans factors contributing to penetration of the blood-brain barrier$204,688
R21 · FY2021 · AI · contact PI
Cryptococcus neoformans factors contributing to penetration of the blood-brain barrier$245,625
R21 · FY2020 · AI · contact PI
14th ASM Conference on Candida and Candidiasis$8,000
R13 · FY2018 · AI · contact PI
AIDS Opportunistic Infections: Virulence of C. glabrata$405,900
R01 · FY2014 · AI · contact PI
AIDS Opportunistic Infections: Virulence of C. glabrata$381,546
R01 · FY2013 · AI · contact PI
AIDS Opportunistic Infections: Virulence of C. glabrata$405,900
R01 · FY2012 · AI · contact PI
AIDS Opportunistic Infections: Virulence of C. glabrata$405,900
R01 · FY2011 · AI · contact PI
Pathogenesis of Candida glabrata in the Urinary Tract$312,661
R01 · FY2011 · DK · contact PI
AIDS Opportunistic Infections: Virulence of C. glabrata$410,000
R01 · FY2010 · AI · contact PI
Pathogenesis of Candida glabrata in the Urinary Tract$326,202
R01 · FY2010 · DK · contact PI
AIDS Opportunistic Pathogens: Targeting the Methyl Citrate Cycle$205,000
R21 · FY2010 · AI · contact PI
Pathogenesis of Candida glabrata in the Urinary Tract$371,302
R01 · FY2009 · DK · contact PI
AIDS Opportunistic Pathogens: Targeting the Methyl Citrate Cycle$227,440
R21 · FY2009 · AI · contact PI
AIDS Opportunistic Infections: Virulence of C. glabrata$186,714
R56 · FY2009 · AI · contact PI
Pathogenesis of Candida glabrata in the Urinary Tract$27,962
R01 · FY2009 · DK · contact PI
Pathogenesis of Candida glabrata in the Urinary Tract$319,009
R01 · FY2008 · DK · contact PI
Pathogenesis of Candida glabrata in the Urinary Tract$50,961
R01 · FY2008 · DK · contact PI
AIDS Opportunistic Infections: Virulence of C. glabrata$387,569
R01 · FY2007 · AI · contact PI
Pathogenesis of Candida glabrata in the Urinary Tract$338,385
R01 · FY2007 · DK · contact PI
AIDS Opportunistic Infectious: Virulence of C. glabrata$399,144
R01 · FY2006 · AI · contact PI
AIDS Opportunistic Pathogens/Fungal Cell Wall Drug Targets$199,573
R21 · FY2006 · DE · contact PI
AIDS Opportunistic Infectious: Virulence of C. glabrata$408,750
R01 · FY2005 · AI
AIDS Opportunistic Pathogens/Fungal Cell Wall Drug Targets$203,750
R21 · FY2005 · DE
AIDS Opportunistic Infections: Virulence of C. glabrata$408,750
R01 · FY2004 · AI
AIDS OPPORTUNISTIC INFECTIONS--VIRULENCE OF C GLABRATA$324,353
R01 · FY2003 · AI
AIDS OPPORTUNISTIC INFECTIONS--VIRULENCE OF C GLABRATA$314,903
R01 · FY2002 · AI
PATHOGENESIS OF CANDIDA GLABRATA IN THE URINARY TRACT$0
P01 · FY2002 · DK
PATHOGENESIS OF CANDIDA GLABRATA IN THE URINARY TRACT$0
P01 · FY2002 · DK
AIDS OPPORTUNISTIC INFECTIONS--VIRULENCE OF C GLABRATA$305,730
R01 · FY2001 · AI
PATHOGENESIS OF CANDIDA GLABRATA IN THE URINARY TRACT$129,815
P01 · FY2001 · DK
PATHOGENESIS OF CANDIDA GLABRATA IN THE URINARY TRACT$0
P01 · FY2001 · DK
AIDS OPPORTUNISTIC INFECTIONS--VIRULENCE OF C GLABRATA$296,824
R01 · FY2000 · AI
PATHOGENESIS OF CANDIDA GLABRATA IN THE URINARY TRACT$129,815
P01 · FY2000 · DK